One Comment

  • March 12, 2023

    cialis on line Although the use of PD biomarkers in preclinical anticancer drug development has become very common and biomarker use is becoming more frequent in phase I clinical trials, very few investigators have fitted their PD data to a PD model 4

Leave a Comment